Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01157819Phase 2Completed
Phase 2, randomised trial of ciprofloxacin in acute otitis externa (AOE) (2 arms), sponsored by Otic Pharma. Primary endpoint: Clinical cure confirmed by significant reduction or absence of the disease symptoms at Day 14. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01157819.